57 Yr female with kco hypertension on tab temlisartan and benidipine od with complaint of bilateral lower limb burning sensation in sole since 6 months with reports attached next line of investigations and possible cause

Reading File
Reading File
Running Command
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

peripheral neuropathy hypertension vitamin D deficiency burning feet

Reading File
Finding Sources
Searching PubMed

vitamin D deficiency peripheral neuropathy burning

Finding Sources
Finding Sources
Searching PubMed

small fiber neuropathy hypertension dyslipidemia prediabetes investigation

Finding Sources
Searching PubMed

peripheral neuropathy workup nerve conduction vitamin B12 thyroid

I now have all the information needed to give a thorough clinical analysis. Let me compile the complete answer.

Clinical Analysis: Ramilaben Valera, 57F - Bilateral Burning Sensation in Soles (6 months)


Lab Report Summary & Interpretation

ParameterValueStatusClinical Significance
HbA1c5.78%PrediabetesTop-of-range prediabetes (5.7-6.4%)
Fasting Glucose97.37 mg/dLNormalNear upper limit
Haemoglobin12.0 g%Low-normalPCV 35.96% (just below normal)
Total Cholesterol220.5 mg/dLHIGHAbove 200
LDL144.49 mg/dLHIGHTarget <100 for her risk profile
HDL36.7 mg/dLLOW<40 is low
Chol/HDL ratio6.01HIGHNormal <4.1 - atherogenic pattern
Triglycerides196.53 mg/dLNear highNear upper limit 200
Vitamin D (25-OH)25.3 ng/mLINSUFFICIENT20-30 = insufficiency
Vitamin B12351.2 pg/mLNormal187-883 range
RFTNormal-Creatinine 0.57, no CKD
LFTNormal-No hepatic cause
UrineNormal-No proteinuria, no glycosuria
ESR20 mm/hrNormal-
ANA (IIF)Pending-Still awaited

Most Likely Causes of Bilateral Burning Soles

1. Prediabetes-Associated Small Fiber Neuropathy (Most Likely)

  • HbA1c 5.78% places her in the prediabetes zone. Even at prediabetes stage, small unmyelinated C-fibers (that carry pain and temperature) are damaged by oxidative stress and advanced glycation end-products (AGEs)
  • Burning dysesthesia restricted to soles with a 6-month duration is the classic presentation of length-dependent small fiber neuropathy
  • Standard NCS/EMG may be normal because it tests large myelinated fibers; small fiber disease requires specific testing (see below)
  • This is the most clinically significant and actionable finding

2. Vitamin D Insufficiency (Contributing cause)

  • 25-OH Vitamin D = 25.3 ng/mL (borderline insufficient, just below the 30 ng/mL normal cut-off)
  • Vitamin D receptors are present on Schwann cells and peripheral neurons. Insufficiency causes neuroinflammation, reduced nerve growth factor, and may independently produce burning neuropathy
  • Several studies link low Vitamin D to both peripheral neuropathy symptoms and their worsening

3. Metabolic Syndrome with Dyslipidemia-Associated Neuropathy

  • She has the full metabolic syndrome triad: borderline prediabetes, hypertension, atherogenic dyslipidemia (high LDL 144, low HDL 36, elevated Chol/HDL 6.01, near-high TG)
  • Dyslipidemia itself (especially low HDL and high TG) is an independent risk factor for peripheral neuropathy through microvascular endoneural ischemia
  • The atherogenic lipid profile is concerning for early microvascular damage to the vasa nervorum

4. Hypertensive Microvascular Neuropathy (Contributing)

  • Long-standing hypertension with KCO (known case of) causes endothelial dysfunction and microvascular ischemia in the vasa nervorum
  • Telmisartan (ARB) and Benidipine (CCB) are appropriate antihypertensives and do not cause neuropathy - so medication toxicity is not a factor here

5. Vitamin B12 - Borderline Interpretation

  • B12 = 351.2 pg/mL is within range, but functional B12 deficiency can occur at values <400 pg/mL in elderly/menopausal women, especially with poor absorption
  • At this age (57F, likely perimenopausal), dietary pattern and gastric acid adequacy should be assessed
  • Not a primary cause here but should not be excluded without serum homocysteine and MMA (methylmalonic acid) levels

6. Hypothyroidism (Must exclude - not tested)

  • Thyroid function has NOT been tested in this report
  • Hypothyroidism causes a painful small fiber neuropathy with burning dysesthesia and is very common in women this age group
  • This is a critical gap in the existing workup

Next Line of Investigations

Tier 1 - Immediate (High Priority)

TestReason
Thyroid Function Tests (TSH, Free T4)Hypothyroidism is a treatable cause of burning neuropathy, very common in 57F; not tested yet
Nerve Conduction Study (NCS) + EMGBaseline electrophysiology; differentiates axonal vs demyelinating; tests large fiber integrity
Fasting Insulin + HOMA-IRAssesses insulin resistance (HbA1c 5.78% suggests insulin resistance even without overt diabetes)
2-hr Post Prandial Glucose (PPBS)HbA1c 5.78% is prediabetes - full OGTT or PPBS needed to characterize glycemic status fully
Serum HomocysteineElevated homocysteine = functional B12/folate deficiency; independent risk factor for neuropathy and cardiovascular disease
ANA (IIF) - PendingAlready ordered; rules out autoimmune neuropathy (Sjogren's, SLE, vasculitis)

Tier 2 - Confirmatory/Specialty

TestReason
Quantitative Sensory Testing (QST)Detects small fiber dysfunction (temperature/pain thresholds); can identify early small fiber neuropathy
Skin Punch Biopsy (IENFD - Intraepidermal Nerve Fiber Density)Gold standard for small fiber neuropathy diagnosis when NCS is normal
Urine Microalbumin / Spot ACR (Albumin:Creatinine Ratio)Screens for early diabetic or hypertensive nephropathy - the same microvascular disease process damages both kidneys and nerves
Serum Methylmalonic Acid (MMA)Most sensitive test for functional B12 deficiency even when serum B12 is in low-normal range
Anti-Ro (SSA), Anti-La (SSB) antibodiesSjogren's syndrome causes painful small fiber neuropathy, particularly in middle-aged women

Tier 3 - If above are normal

TestReason
SPEP (Serum Protein Electrophoresis)Rules out paraproteinemia/monoclonal gammopathy as a cause
Folic Acid levelFolate deficiency can cause neuropathy, especially combined with borderline B12
CBC with peripheral smear reviewPCV 35.96% (mildly low); assess for subtle nutritional anemia contribution
Renal Doppler / eGFR calculationLong-standing HTN - assess for CKD grade even though current creatinine is normal

Management Approach (Alongside Investigations)

  1. Vitamin D replacement: 60,000 IU/week cholecalciferol for 8 weeks, then monthly maintenance (target >50 ng/mL)
  2. Statin therapy: Strongly indicated - LDL 144 + atherogenic dyslipidemia + hypertension + prediabetes = high cardiovascular risk. Rosuvastatin 10-20 mg or Atorvastatin 20-40 mg
  3. Lifestyle modification: Mediterranean-style diet, aerobic exercise 150 min/week; targets both prediabetes reversion and dyslipidemia
  4. HbA1c monitoring: Recheck in 3 months; if persistent prediabetes or progression to diabetes, initiate Metformin (which also has some neuroprotective effects)
  5. Symptomatic neuropathy relief: While investigations are ongoing - Pregabalin 75 mg BD or Duloxetine 30-60 mg OD can be used for symptomatic burning relief; add Mecobalamin 500 mcg TID
  6. ANA result follow-up: If positive, rheumatology referral for full autoimmune workup

Summary Flowchart

Bilateral burning soles (6 months) + 57F + HTN + Prediabetes (HbA1c 5.78%)
    ↓
Confirmed findings: Prediabetes | Dyslipidemia | Vit D insufficiency | Borderline PCV
    ↓
NOT yet tested: Thyroid (TSH) | NCS/EMG | Homocysteine | PPBS/OGTT | MMA | ANA (pending)
    ↓
Most likely: Small fiber neuropathy from metabolic syndrome (prediabetes + dyslipidemia + HTN + Vit D insufficiency)
    ↓
Next urgent step: TSH + NCS/EMG + Fasting insulin + PPBS + Homocysteine

Key takeaway: This patient does not yet have overt diabetes (HbA1c 5.78% = prediabetes) but burning sole neuropathy at this stage is well-recognized and is likely multifactorial - driven by insulin resistance, atherogenic dyslipidemia with vasa nervorum ischemia, Vitamin D insufficiency, and long-standing hypertension. The most important missing test right now is TSH (hypothyroidism), followed by NCS/EMG and 2-hr PPBS. Vitamin D replacement and statin therapy should be initiated now while investigations proceed.
  • Harrison's Principles of Internal Medicine 22E, Chapter 457 (Peripheral Neuropathy), p. 3638
This is a shared conversation. Sign in to Orris to start your own chat.